MedPath

The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat

Completed
Conditions
Aging
Interventions
Other: Residential Insight Meditation Retreat
Registration Number
NCT03056105
Lead Sponsor
University of California, Davis
Brief Summary

The purpose of this study was to examine how participation in a 1 month intensive Insight (vipassana) Meditation retreat (a) affects biological markers of cellular aging, social affiliation, and inflammation, which are important for physical health, longevity, and behavior, and (b) to relate observed biological changes to baseline levels and changes in psychological traits, which may underlie improvements in personal adaptive functioning.

Detailed Description

The investigators are specifically assessing the effects of retreat on telomere length and telomerase levels in participants' white blood cells, as well as plasma levels of interlukin-6 (IL-6), to assess how the retreat experience impacts these markers of cellular aging and inflammation. The hypotheses are that retreat participation will increase both telomere length and telomerase activity, but decrease IL-6 levels. The investigators will also assess the impact of retreat participation on oxytocin-a hormone involved in a number of physiological and behavioral processes, including affiliative bonds and stress responses-the hypothesis being that participation in the retreat will increase plasma oxytocin levels. The investigators will then explore how these and other biomarkers relate to psychological processes and personality traits, which may also be altered by participation in the meditation retreat.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
66
Inclusion Criteria
  • Previous meditation experience equivalent to two 5-10 day residential meditation retreats
Read More
Exclusion Criteria
  • Disclosure of potentially contagious blood-borne illness (e.g., HIV, Hepatitis, etc.) or other illnesses that might interfere with telomere or telomerase measurement
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
RetreatResidential Insight Meditation RetreatParticipants registered for a one-month, residential Insight Meditation retreat held at Spirit Rock Meditation Center in either February or March, 2013
Primary Outcome Measures
NameTimeMethod
Oxytocinchange from the start of retreat to three weeks into the retreat period

an affiliative hormone associated with social bonding in both men and women, and which downregulates inflammatory cytokines

Telomerasechange from the start of retreat to three weeks into the retreat period

an enzyme that repairs the shortening of telomeres that occurs during aging

Telomere lengthchange from the start of retreat to three weeks into the retreat period

the repetitive sequence of DNA that serves as a protective cap to eukaryotic chromosomes, which protects from degradation and instability and is related to longevity

Interleukin-6change from the start of retreat to three weeks into the retreat period

a primary measure of inflammation, which is influenced by psychological stress

Secondary Outcome Measures
NameTimeMethod
pro- and anti-inflammatory cytokines (IL-1b, IL-2, IL-4, IL-5, IL-10, IL-12 (p70), IL-13, IFN-γ, TNF-α)two measurements, three weeks apart

a family of proteins involved in generating and regulating the immune system

Brain Derived Neurotrophic Factortwo measurements, three weeks apart

a protein related to neuroplasticity, learning, and memory, which is decreased in depression

Lifestyle Profile IItwo measurements, three weeks apart

Assesses health-promoting lifestyle factors (Walker et al., 1987)

Experience in Close Relationships, short formtwo measurements, three weeks apart

Assesses attachment anxiety (fear of rejection or abandonment) and avoidance (avoidance of intimacy and interdependence) (ECR-12: Lafontaine et al., 2015)

Non-attachment Scaletwo measurements, three weeks apart

Assesses non-attachment from a Buddhist perspective (NAS; Sahdra, Shaver \& Brown, 2010)

Psychological Wellbeing Scaletwo measurements, three weeks apart

Assess autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance (PWBS; Ryff, 1989)

Mysticism Scaletwo measurements, three weeks apart

Assesses mystical experience and religious interpretation (M-Scale; Hood, 1975)

Big Five Inventorytwo measurements, three weeks

Assesses extraversion, agreeableness, conscientiousness, openness to experience, neuroticism (BFI; Goldberg, 1993)

Self-Assessed Wisdom Scaletwo measurements, three weeks apart

Assess five dimensions of wisdom: 1) Experience, 2) Emotional Regulation, 3) Reminiscence and Reflectiveness, 4) Openness, 5) Humor (SAWS; Webster, 2003)

Ego Resiliency Scaletwo measurements, three weeks apart

Assesses the ability to adapt one's level of control temporarily up or down as circumstances dictate (EGO; Block \& Kremen, 1996)

Five Facet Mindfulness Questionnairetwo measurements, three weeks apart

Assesses five facets of mindfulness: 1) Non-reactivity to Inner Experience, 2) Observing 3) Acting with Awareness, 4) Describing, and 5) Non-judging of Experience (FFMQ; Baer et al., 2006)

Three Dimensional Wisdom Scaletwo measurements, three weeks

Assess three dimensions of wisdom: 1) Cognitive, 2) Reflective, and 3) Affective (3-DWS; Ardelt, 2003)

Difficulties in Emotion Regulation Scaletwo measurements, three weeks

Assesses non-acceptance to one's emotional responses, difficulty achieving goals, impulsiveness, lack of emotional awareness, access to emotion regulation strategies, emotional clarity (DERS; Gratz \& Roemer, 2004)

Arginine Vasopressintwo measurements, three weeks apart

a less commonly studied affiliative hormone also associated with close social bonds

State-Trait Anxiety Inventorytwo measurements, three weeks apart

10 item scale designed to assess trait-anxiety (STAI; Spielberger et al., 1983)

Center for Epidemiological Studies Depression Scaletwo measurements, three weeks apart

Assesses depressive symptomatology (CES-D; Radloff, 1977)

Trial Locations

Locations (1)

University of California, Davis

🇺🇸

Davis, California, United States

© Copyright 2025. All Rights Reserved by MedPath